Clinical and Economic Comparison of Ceftaroline Fosamil (CPT) and Daptomycin (DAP) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1424
Abstract: 1894. Clinical and Economic Comparison of Ceftaroline Fosamil (CPT) and Daptomycin (DAP) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI) Evan J. Zasowski, PharmD, BCPS; Trang D. Trinh, PharmD; Kimberly Claeys, PharmD, BCPS; Abdalhamid M.… read more here.
Keywords: comparison ceftaroline; university; pharmacy; clinical economic ... See more keywords